Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 6974-99-8
2. Nsc22053
3. 1h-indene,2,3-dihydro-2,4,7-trimethyl-
4. Dtxsid40281578
5. Zinc1589737
6. Nsc-22053
7. 1h-indene,3-dihydro-2,4,7-trimethyl-
8. Ds-002906
| Molecular Weight | 160.25 g/mol |
|---|---|
| Molecular Formula | C12H16 |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 0 |
| Rotatable Bond Count | 0 |
| Exact Mass | 160.125200510 g/mol |
| Monoisotopic Mass | 160.125200510 g/mol |
| Topological Polar Surface Area | 0 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 143 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Cerata Pharmaceuticals LLP: WHO-GMP Certified Leading Manufacturer & Exporter of Steroid-Hormone & Peptide APIs From India.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32001
Submission : 2017-08-23
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34895
Submission : 2020-05-27
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34904
Submission : 2020-06-10
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35035
Submission : 2020-07-29
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35036
Submission : 2020-08-03
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35921
Submission : 2021-05-11
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
44
PharmaCompass offers a list of Microcrystalline Cellulose API API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Microcrystalline Cellulose API manufacturer or Microcrystalline Cellulose API supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Microcrystalline Cellulose API manufacturer or Microcrystalline Cellulose API supplier.
PharmaCompass also assists you with knowing the Microcrystalline Cellulose API API Price utilized in the formulation of products. Microcrystalline Cellulose API API Price is not always fixed or binding as the Microcrystalline Cellulose API Price is obtained through a variety of data sources. The Microcrystalline Cellulose API Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NSC 22053 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NSC 22053, including repackagers and relabelers. The FDA regulates NSC 22053 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NSC 22053 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NSC 22053 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A NSC 22053 supplier is an individual or a company that provides NSC 22053 active pharmaceutical ingredient (API) or NSC 22053 finished formulations upon request. The NSC 22053 suppliers may include NSC 22053 API manufacturers, exporters, distributors and traders.
click here to find a list of NSC 22053 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A NSC 22053 DMF (Drug Master File) is a document detailing the whole manufacturing process of NSC 22053 active pharmaceutical ingredient (API) in detail. Different forms of NSC 22053 DMFs exist exist since differing nations have different regulations, such as NSC 22053 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A NSC 22053 DMF submitted to regulatory agencies in the US is known as a USDMF. NSC 22053 USDMF includes data on NSC 22053's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The NSC 22053 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of NSC 22053 suppliers with USDMF on PharmaCompass.
NSC 22053 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NSC 22053 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NSC 22053 GMP manufacturer or NSC 22053 GMP API supplier for your needs.
A NSC 22053 CoA (Certificate of Analysis) is a formal document that attests to NSC 22053's compliance with NSC 22053 specifications and serves as a tool for batch-level quality control.
NSC 22053 CoA mostly includes findings from lab analyses of a specific batch. For each NSC 22053 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NSC 22053 may be tested according to a variety of international standards, such as European Pharmacopoeia (NSC 22053 EP), NSC 22053 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NSC 22053 USP).